We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Supplement Makers Hit With Warning Letters for Marketing Unapproved Drugs
Supplement Makers Hit With Warning Letters for Marketing Unapproved Drugs
Two Oregon supplement makers are in the FDA’s crosshairs for marketing their products for a range of unapproved conditions, including regulating blood pressure and alleviating panic attacks.